Analysis of the apoptotic and therapeutic effects of histone deacetylase inhibitors on multiple myeloma

多发性骨髓瘤（MM）是一种血液中浆细胞的不可治愈的进行性癌症。它是第二常见的血液癌症，占所有癌症相关死亡的2%。统计数字显示，发病率在上升，发病年龄在下降。MM的原因和进展知之甚少，目前的治疗经常伴随复发。该项目将评估针对MM细胞存活的令人兴奋的新疗法，从而在未来实现更有效的治疗。

Multiple myeloma (MM) is an incurable progressive cancer of plasma cells within blood. It is the second most common blood cancer and represents 2% of all cancer-related deaths. Statistics show increasing incidence and decreasing age of onset. The cause and progression of MM is poorly understood and current treatments are frequently followed by relapse. This project will assess exciting new therapies against the survival of MM cells leading to more effective treatments in the future.